One-page summary for health professionals and immunisation practitioners giving vaccinations. It is based on the Green Book and helps health professionals vaccinate people correctly to protect them and their families from disease.
This document contains recommendations for frontline emergency service workers, on how to prevent and control exposure to common blood-borne viruses (BBVs) such as hepatitis C and HIV. The document includes: recommended actions in the event of a potential exposure care pathways
This document explains how infection control staff in NHS hospitals can report suspected or confirmed outbreaks of norovirus to Public Health England via the Hospital Norovirus Outbreak Reporting System (HNORS) website. It includes case and outbreak definitions which ensure standardisation
This guide provides further information on the recently updated NICE Guideline (CG71) Familial Hypercholesterolaemia: identification and management. It includes: a summary of recommendations from the recent update of the document an outline of national and European policy documents best practice case
The technologies described in this briefing are remote electrocardiogram (ECG) interpretation consultancy services. They are used for assisting in diagnosing and decision-making for people with cardiovascular disease. The innovative aspects are that with remote ECG interpretation, a person does not need to travel
Thetechnologies described in this briefing are 21 mechanical thrombectomy devices of 2 types: stent retrievers and aspiration catheters. They are used to remove blood clots from a main cerebral artery to restore blood flow after acute ischaemic stroke. The innovative aspects are that
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults. Dupilumab is recommended as an option for treating moderate to severe atopic dermatitis in adults, only if: the disease has not responded to at least 1 other
This quality standard covers diagnosing and managing endometriosis in women, including young women aged 17 and under. It describes high-quality care in priority areas for improvement.
Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis in adults. Ixekizumab alone, or with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as described in NICE’s technology appraisal